These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17966605)

  • 21. Buprenorphine withdrawal syndrome in a newborn.
    Marquet P; Chevrel J; Lavignasse P; Merle L; Lachâtre G
    Clin Pharmacol Ther; 1997 Nov; 62(5):569-71. PubMed ID: 9390114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug dependence in pregnancy. Better to substitute than complete withdrawal].
    Ottenjann H
    MMW Fortschr Med; 2000 Apr; 142(17):16. PubMed ID: 10879015
    [No Abstract]   [Full Text] [Related]  

  • 23. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population.
    Jumah NA; Edwards C; Balfour-Boehm J; Loewen K; Dooley J; Gerber Finn L; Kelly L
    BMJ Open; 2016 Oct; 6(10):e011774. PubMed ID: 27799240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Narcotic dependency in pregnancy. Methadone maintenance compared to use of street drugs.
    Stimmel B; Adamsons K
    JAMA; 1976 Mar; 235(11):1121-4. PubMed ID: 946208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience.
    Vucinovic M; Roje D; Vucinovic Z; Capkun V; Bucat M; Banovic I
    Yonsei Med J; 2008 Oct; 49(5):705-13. PubMed ID: 18972589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic opioid use during pregnancy: maternal and fetal implications.
    Stanhope TJ; Gill LA; Rose C
    Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
    Fischer G; Ortner R; Rohrmeister K; Jagsch R; Baewert A; Langer M; Aschauer H
    Addiction; 2006 Feb; 101(2):275-81. PubMed ID: 16445556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal and neonatal outcomes following methadone substitution during pregnancy.
    Greig E; Ash A; Douiri A
    Arch Gynecol Obstet; 2012 Oct; 286(4):843-51. PubMed ID: 22584603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome.
    Lam SK; To WK; Duthie SJ; Ma HK
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):216-21. PubMed ID: 1445130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair.
    Su PH; Chang YZ; Yang C; Ng YY; Chen JY; Chen SC
    Pediatr Neonatol; 2012 Apr; 53(2):112-7. PubMed ID: 22503258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.
    Lemon LS; Naimi A; Caritis SN; Platt RW; Venkataramanan R; Bodnar LM
    Paediatr Perinat Epidemiol; 2018 Mar; 32(2):213-222. PubMed ID: 29372750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
    Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
    Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary gland volume among heroin users stabilised on substitution pharmacotherapy.
    Lorenzetti V; Lubman DI; Velakoulis D; Yücel M
    Drug Alcohol Depend; 2010 Jul; 110(1-2):164-6. PubMed ID: 20303678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving treatment outcome in pregnant opiate-dependent women.
    Chang G; Carroll KM; Behr HM; Kosten TR
    J Subst Abuse Treat; 1992; 9(4):327-30. PubMed ID: 1479630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?
    Hensley L; Sulo S; Kozmic S; Parilla BV
    J Addict Med; 2018; 12(1):61-64. PubMed ID: 29068826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.